QUANTUM GENOMICS: Quantum Genomics Publishes its 2022 First

Quantum Genomics Publishes its 2022 First Half Results
and Reviews its Activity
Quantum Genomics (Euronext Growth - FR0011648971 - ALQGC), a biopharmaceutical company specialising in the development

Related Keywords

United States , France , Taiwan , Paris , France General , South Korea , Turkey , Brazil , French , American , Jean Philippe Milon , Catherine Llorens Cort , Mike Tattory , Gulf Pharmaceutical Industries Julphar , American Heart Association , Linkedin , Twitter , France French National Institute Of Health , Drug Administration , Scientific Centre For National Research , Descartes University , Quantum Genomics Publishes , Euronext Growth , Philippe Milon , Quantum Genomics , Middle East , Independent States , Statutory Auditor , Brain Aminopeptidase , Paris Descartes University , French National Institute , Medical Research , Scientific Centre , National Research , Quantum , Genomics , Ublishes , 022 , First , Calf , Results , Reviews , Activity ,